342 Cardiology Clinics Acquired by Private Equity Firms in 2013 to 2023

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, July 3, 2024 -- From 2013 to 2023, 342 cardiology clinics were acquired by private equity firms, with 94.7 percent of the acquisitions occurring between 2021 and 2023, according to a study published online June 30 in the Journal of the American College of Cardiology to coincide with the AcademyHealth 2024 Annual Research Meeting, held from June 29 to July 2 in Baltimore.

Victoria L. Bartlett, M.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues examined the number of private equity acquisitions of cardiology practices between January 2013 and September 2023.

The researchers found there were 41 acquisitions of outpatient cardiology practices by private equity firms during the study period, corresponding to 342 clinic sites. There was an increase seen in the number of clinic sites acquired per year, from 0 in 2013 to 215 in 2023; 94.7 percent of the acquisitions occurred from 2021 to 2023. Sixty-four clinic sites were acquired twice, resulting in 278 unique cardiology clinic sites acquired, representing 2.9 percent of all U.S. cardiology clinics. Cardiology clinics were significantly less likely to be acquired when located in the highest poverty communities versus the wealthiest communities (top versus bottom poverty quartile, 2.0 versus 2.9 percent; adjusted rate ratio, 0.61). The likelihood of being acquired was higher for clinics located in the South or West than those in the Northeast (4.3 and 3.8 percent, respectively, versus 1.5 percent; adjusted rate ratios, 3.17 and 2.60, respectively).

"As the number of cardiology acquisitions by private equity increases, it will be critical to monitor the effects on procedural utilization, quality, and outcomes for patients with cardiovascular disease," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords